Literature DB >> 19402838

Sclerosing haemangioma with lymph node metastasis.

Nai-Chuan Chien1, Chih-Wen Lin, Jeh-En Tzeng.   

Abstract

Sclerosing haemangioma (SH) of the lung is an intrapulmonary tumour composed of polygonal and cuboidal cells arranged in a heterogeneous pattern. SH is generally regarded as benign or very low-grade; only rarely have cases of lymph node metastasis been reported. We report a case of SH with metastasis to the regional lymph nodes in an 18-year-old male, whose left lung tumour was identified incidentally on routine CXR. The left upper lobe was removed and the regional lymph nodes dissected. The tumour consisted of proliferative cuboidal and polygonal cells arranged in a papillary pattern within the sclerotic stroma. Subcapsular metastasis was observed in a lymph node. SH with lymph node metastasis was diagnosed. The patient was disease-free at follow up after 2 years. Lobectomy with nodal dissection is suggested for the treatment of pulmonary SH, especially in the case of large tumours with enlargement of regional lymph nodes. Investigation of more cases and long-term follow up are necessary to assess the clinical significance of lymph node metastasis.

Entities:  

Mesh:

Year:  2009        PMID: 19402838     DOI: 10.1111/j.1440-1843.2009.01523.x

Source DB:  PubMed          Journal:  Respirology        ISSN: 1323-7799            Impact factor:   6.424


  8 in total

1.  Sclerosing Pneumocytoma of the Lung: A Case Report.

Authors:  Vasugi Gramani Arumugam; Leena Dennis Joseph; Periyasamy Thangavel; Rajendiran Swaminathan; Ramya Rathinam Sunderaj
Journal:  J Clin Diagn Res       Date:  2017-02-01

2.  Pneumocytoma: a Case Report and Review of Literature.

Authors:  Rexeena Bhargavan; K Chandramohan; Arun Peter Mathew; Sindhu Nair
Journal:  Indian J Surg Oncol       Date:  2017-04-08

3.  18F-FDG PET/CT characteristics of pulmonary sclerosing hemangioma vs. pulmonary hamartoma.

Authors:  Lei Jiang; Yan Huang; Qiying Tang; Qingping Zhao; Yuan Li; Xiaodong Wu; Huoqiang Wang
Journal:  Oncol Lett       Date:  2018-05-08       Impact factor: 2.967

4.  Treatment of 28 patients with sclerosing hemangioma (SH) of the lung.

Authors:  Yang Lei; Duan Yong; Ruan Jun-Zhong; Yang Zhi; Wang Zi-Tong
Journal:  J Cardiothorac Surg       Date:  2012-06-18       Impact factor: 1.637

Review 5.  Pulmonary sclerosing pneumocytoma: clinical features and prognosis.

Authors:  Quan Zheng; Jian Zhou; Guangchen Li; Shulei Man; Zhangyu Lin; Tengyong Wang; Boran Chen; Feng Lin
Journal:  World J Surg Oncol       Date:  2022-04-30       Impact factor: 3.253

6.  Clinical Characteristics of Malignant Pulmonary Sclerosing Pneumocytoma Based on a Study of 46 Cases Worldwide.

Authors:  Weidong Zhang; Dong Cui; Yaqian Liu; Kefeng Shi; Xia Gao; Rulin Qian
Journal:  Cancer Manag Res       Date:  2022-08-13       Impact factor: 3.602

7.  Pulmonary sclerosing hemangioma: a unique epithelial neoplasm of the lung (report of 26 cases).

Authors:  Bojiang Chen; Jun Gao; Hong Chen; Yidan Cao; Xin He; Wen Zhang; Man Luo; Shangfu Zhang; Weimin Li
Journal:  World J Surg Oncol       Date:  2013-04-15       Impact factor: 2.754

8.  Pulmonary sclerosing hemangioma: report of two cases.

Authors:  Chuang He; Hongyang Fang; Yun Liu; Xuequan Huang; Wei Zhen; Li Ren
Journal:  World J Surg Oncol       Date:  2012-09-03       Impact factor: 2.754

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.